June 1, 2021Open Access

Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images

Key Points

Key points are not available for this paper at this time.

Abstract

Hence, we propose DLS as a surrogate or substitute for IHC-determined PD-L1 measurement to guide individual pretherapy decisions pending in larger prospective trials.

Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images

Key Points

Abstract

Cite This Study